Granules India has acquired Swiss CDMO firm Senn Chemicals AG for CHF 20 million, expanding into the peptide therapeutics segment. The acquisition, expected to complete by mid-2025, aims to leverage Senn's peptide synthesis expertise with Granules' large-scale manufacturing capabilities to deliver high-quality peptide-based solutions globally.
